The Equatorial Guinea Malaria Vaccine Initiative (EGMVI) highlights how long-term African government and international energy industry investment, plus novel partnerships, can enable clinical development of vaccines in Africa, for Africa. We review achievements and challenges of this pioneering, award-winning, public-private partnership which offers a model for future Africa-centric clinical research and development (R&D).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pt.2024.03.005 | DOI Listing |
Publication Analysis
Top Keywords
equatorial guinea
8
clinical development
8
paradigm africa-centric
4
africa-centric vaccine
4
vaccine development
4
development equatorial
4
guinea equatorial
4
guinea malaria
4
malaria vaccine
4
vaccine initiative
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!